Outcomes of Coronavirus Patients Treated with Extracorporeal Membrane Oxygenation in China Offers Guidance for Management of Critically Ill COVID-19 Patients Worldwide

The initial experience of extracorporeal membrane oxygenation (ECMO) management for coronavirus 2019 (COVID-19) patients in Shanghai, China provides guidance for management of critically ill COVID-19 patients worldwide, reports a study in the ASAIO Journal. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Read more